Hemophilia Drug Hits Mark in Trial

(MedPage Today) -- A coagulation factor replacement therapy for hemophilia B met its primary efficacy and safety objectives in a phase III trial, its developers said. via MedPageToday.com - medical news plus CME for physicians Read More Here..